Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merck KGaA Sticks With Structure, Eyes Smaller Healthcare Deals

Nov 09 2023

• By Kevin Grogan

Helene von Roeder — Helene von Roeder • Source: merck kgaa

Related Content

Sandoz Stands Alone As It Completes Novartis Spinoff

Oct 04 2023

Bayer To Split Off Consumer Or Crop Science, Or Both, Or Neither

Nov 08 2023

Sanofi Stock Slides On Lower Profit Forecast And Consumer Health Spinoff Plan

Oct 27 2023

ESMO 23: Madrid Meeting Hails Padcev/Keytruda Combo As New Bladder Cancer Standard Of Care

Oct 23 2023

Clinical Hold For Merck KGaA’s BTK Inhibitor Evobrutinib For MS Raises Class Safety Fears

Apr 12 2023

Related Companies

Bayer AG

Sanofi

Merck KGaA

Johnson & Johnson

Pfizer Inc.

GSK plc

Novartis AG

Sandoz Inc.

Procter & Gamble

Jiangsu Hengrui Pharmaceuticals

AstraZeneca PLC

Seagen Inc.

Astellas Pharma, Inc.

Merck & Co., Inc.

Additional Topics

Sales & Earnings Business Strategies Clinical Trials Commercial Cancer BioPharmaceutical

More from Earnings

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window